Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC Management in Major Trauma Bleeding
NCT06627218Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2021
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of prothrombin complex concentrate, human in traumatic hemorrhage (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: In-hospital mortality at 14 days. Started Jan 2021; status: recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT06627218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06627218.